-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Evolutionary Genomics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2014 to 2020.
- Evolutionary Genomics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was $0.000.
- Evolutionary Genomics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $148K.
- Evolutionary Genomics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2016 was $156K, a 16.3% increase from 2015.
- Evolutionary Genomics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2015 was $134K.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)